Top Markets
Coin of the day
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Classement en actions #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Prix de l'action
$0.0039
Dernière synchronisation: 2023-10-27
Capitalisation boursière
$235.97K
Changement (1 jour)
-13.33%
Changement (1 an)
0.00%
Pays
US
Échange Infinity Pharmaceuticals, Inc. (INFI)

Catégorie

Le prix INFI avec la capitalisation boursière de B
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
INFI
$0.0039
Capitalisation boursière de Infinity Pharmaceuticals, Inc.(INFI)
Capitalisation boursière: $235.97K
En August 2026, Infinity Pharmaceuticals, Inc. a une capitalisation boursière de $235.97K. Cela fait de Infinity Pharmaceuticals, Inc. la 40134th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Infinity Pharmaceuticals, Inc. du 2000 au 2026
INFI par rapport au top 5 des plus populaires stocks
Prix pour INFI L’actif B La capitalisation boursière de B Résultats
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$90,396.06 $235.97K
$5.470T +2,317,847,615.15%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$73,828.11 $235.97K
$4.467T +1,893,028,379.22%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$68,990.85 $235.97K
$4.174T +1,768,996,165.18%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$61,151.86 $235.97K
$3.700T +1,567,996,335.13%
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.
$47,174.25 $235.97K
$2.854T +1,209,596,025.46%